- Report
- April 2025
- 200 Pages
Global
From €4101EUR$4,490USD£3,507GBP
- Report
- March 2025
- 150 Pages
Global
From €4430EUR$4,850USD£3,788GBP
- Report
- July 2023
- 284 Pages
Global
From €3288EUR$3,600USD£2,812GBP
- Report
- February 2024
- 83 Pages
Global
From €3500EUR$4,105USD£3,098GBP
- Report
- April 2025
- 50 Pages
Global
From €2420EUR$2,650USD£2,070GBP
- Report
- June 2023
- 313 Pages
Global
From €3261EUR$3,570USD£2,788GBP
Penicillin G is an antibiotic drug used to treat a variety of bacterial infections. It is a narrow-spectrum antibiotic, meaning it is effective against a limited range of bacteria. Penicillin G is derived from the Penicillium mold, and is one of the oldest and most widely used antibiotics. It is used to treat infections caused by Gram-positive bacteria, such as streptococci and staphylococci. It is also used to treat some Gram-negative bacteria, such as Neisseria gonorrhoeae. Penicillin G is available in both injectable and oral forms, and is often used in combination with other antibiotics.
The market for Penicillin G is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, Novartis, and AstraZeneca. Show Less Read more